PharmaReports: Metabolic & Hormonal Disorders
LeadDiscovery offers full reports in selected areas of the pharmaceutical and biotech sector.
Each of the reports below has been especially selected by LeadDiscovery. Browse the reports or try our search engine.
Reports featured here primarily focus on diabetes and obesity. Cachexia is also a focus of this channel as is metabolic dysfunction relating to pharmacological treatment (for example following treatment for HIV infection). Reports relating to hormonal disorders or diseases due to hormonal change (eg osteoporosis) can be featured here.
Showing results 101 - 123 of 123
- The Future of Targeted Therapeutics: Key technologies, new therapy area applications and leading players
- HRT for Menopausal Symptoms: Commercial Opportunities and Pipeline Insight
- Outsourcing in Drug Discovery
- World Wound Care Markets 2008 - Burns, Skin Ulcers, Surgical and Trauma Wounds
- Pipeline Insight: Non-insulin antidiabetics - Incretin mimetics, GLP-1 agonists and DPP-IV inhibitors
- Lipitor Market analysis and forecasts
- Monoclonal Antibodies Report: 2008 Update
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Non-hormonal Treatments for Menopausal Symptoms
- World Wound Care Markets 2008
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Osteoporosis & Bone Metabolism Disorders Market 2008-2023
- Pipeline Insight: Insulin antidiabetics
- Forecast Insight: Antidiabetics - Switching to new molecule antidiabetics drives market growth
- Forecast Insight: Dyslipidemia - Genericization and negative trial data drive market shrinking
- Glucose Testing Markets
- Ion Channel Trends 2008
- Kinase Screening & Profiling Trends 2008
- GPCR Screening & Profiling Trends 2008
- Women's Reproductive Disorders Therapeutics 2008-2018
- Critical Limb Ischemia: Western Europe Epidemiology
- Drug Delivery Technologies - Current Market Dynamics, Future Market Opportunities and Lifecycle Strategies
- The Future of RNAi Therapeutics: Drug Pipelines and Prospects
Browse our theraputic areas for other entries:
- Oncology
- Cancer Immunotherapy
- Immunology & Inflammatory Diseases
- Infectious Diseases
- Psychiatric, Addictive & Sleep Disorders
- Pain
- Neurodegenerative & Neuroelectrophysiological Disorders
- Metabolic & Hormonal Disorders
- Cardiovascular Disorders
- GenitoUrinary Tract Disorders
- Technology
- Diagnostics & Devices
- Other Theraputic Areas, Pharmaceutical Strategy and Development